Literature DB >> 32916253

Retroprosthetic membrane: A complication of keratoprosthesis with broad consequences.

Jennifer Park1, Pakornkit Phrueksaudomchai2, M Soledad Cortina3.   

Abstract

Keratoprosthesis (KPro) devices have the remarkable ability to restore vision in patients suffering from corneal blindness who are poor candidates for traditional penetrating keratoplasty. However, eyes with KPro can experience various complications, including the development of retroprosthetic membrane (RPM). RPMs reduce visual acuity in patients due to physical obstruction of the visual axis, but studies have shown that RPM can also lead to a variety of other consequences, from melting of the corneal carrier graft to precipitating retinal detachments. Histopathologic studies have shown that RPMs are composed of elements from both the recipient and donor. The presence of myofibroblasts in RPMs imparts them with contractile properties, which can contribute to their downstream complications, including angle closure, hypotony, and retinal detachment. At present, there are limited treatments to combat the growth of RPM. Future therapies could include anti-metabolites and targeted anti-inflammatory treatments, as well as device coatings or textured device surfaces that can hinder RPM proliferation. The long-term success of KPro depends on devising an effective solution for preventing RPM growth.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Back plate; Corneal melt; Hypotony; Keratocyte; Keratoprosthesis (KPro); Myofibroblast; Polymethyl methacrylate (PMMA); Retroprosthetic membrane (RPM); Titanium

Mesh:

Year:  2020        PMID: 32916253     DOI: 10.1016/j.jtos.2020.09.004

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  4 in total

1.  Critical media attributes in E-beam sterilization of corneal tissue.

Authors:  Sina Sharifi; Hannah Sharifi; Ali Akbari; Fengyang Lei; Claes H Dohlman; Miguel Gonzalez-Andrades; Curtis Guild; Eleftherios I Paschalis; James Chodosh
Journal:  Acta Biomater       Date:  2021-10-28       Impact factor: 8.947

Review 2.  The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.

Authors:  Steven Bonneau; C Maya Tong; Yelin Yang; Mona Harissi-Dagher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-06       Impact factor: 3.535

3.  Toward electron-beam sterilization of a pre-assembled Boston keratoprosthesis.

Authors:  Sina Sharifi; Hannah Sharifi; Curtis Guild; Mohammad Mirazul Islam; Khoa D Tran; Corrina Patzer; Claes H Dohlman; Eleftherios I Paschalis; Miguel Gonzalez-Andrades; James Chodosh
Journal:  Ocul Surf       Date:  2021-03-03       Impact factor: 5.033

4.  Ultra-wide field imaging to assess the optic nerve and retina in Boston type I and II keratoprosthesis patients.

Authors:  William R Bloom; Matthew D Karl; Sarah B Smith; Yusra F Shao; William Terrell; Ahmad B Tarabishy; Andrew J Hendershot; Rebecca A Kuennen; Tyler D Oostra; Thomas F Mauger; Colleen M Cebulla
Journal:  Eye Vis (Lond)       Date:  2022-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.